In 2023, the mortality due to pancreas malignant neoplasms in Brazil among males stood at approximately 6.70 thousand. The forecast from 2024 to 2028 suggests a steady increase in mortality rates, rising from 6.91 thousand in 2024 to 7.77 thousand in 2028. This unfaltering upward trend, with a notably significant year-on-year growth averaging around 2.5%, highlights the growing burden of pancreatic cancer in Brazil.

Future trends to watch for:

Increased investment in early detection technologies and treatments could modify the mortality trajectory.
Public health initiatives focusing on prevention and awareness can impact long-term trends.
Potential breakthroughs in personalized medicine may offer new hope in reducing mortality rates.